CD34 in mice behaves fundamentally differently from CD34 in humans, and that difference has shaped decades of stem cell research. In human bone marrow, CD34 reliably marks the stem cells used in transplantation medicine. In the adult mouse, the most primitive blood-forming stem cells are mostly CD34-negative, a discovery that initially confused the field and continues to influence how researchers design experiments. Understanding how CD34 functions in mice, where it shows up, and what it does across tissues beyond the blood system is essential for anyone working with mouse models in stem cell biology, cancer research, or regenerative medicine.
Why Adult Mouse Blood Stem Cells Are Mostly CD34-Negative
The biggest surprise about CD34 in mice came in the mid-1990s, when researchers found that the long-term reconstituting stem cells in adult mouse bone marrow sit in the CD34-low to CD34-negative fraction, not the CD34-positive fraction that everyone expected based on the human data.1PubMed. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell This was a jarring result. In human medicine, CD34 had become the go-to marker for isolating transplantable stem cells. The assumption was that CD34 would behave the same way in mice, and it simply did not.
Subsequent work using transgenic mice carrying human CD34 genomic constructs helped explain part of the puzzle. In these mice, the human version of CD34 was expressed even in the murine CD34-negative stem cell population, suggesting that the two species regulate the CD34 gene differently at the transcriptional level rather than housing stem cells in fundamentally different compartments.2PubMed Central. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells In other words, the mouse stem cells that would be CD34-positive if they were human are there in the bone marrow. They just do not turn on mouse CD34 under resting conditions.
CD34 Expression Shifts with Age and Activation
The story becomes more nuanced when you look at different life stages. In the fetal mouse and in young animals up to about five weeks old, virtually all long-term engrafting stem cells express CD34. The shift to a predominantly CD34-negative stem cell pool begins around seven weeks of age and is largely complete by ten weeks, though a small population of CD34-positive stem cells persists into adulthood.3Experimental Hematology. Developmental changes of CD34 expression by murine hematopoietic stem cells Researchers working with mice younger than seven weeks, or using fetal liver as a stem cell source, should not assume the same CD34 expression patterns they see in adult bone marrow.
Beyond the developmental timeline, CD34 expression on adult mouse stem cells is also reversible and tied to the cell’s activation state. When stem cells are pushed into cycle by the chemotherapy drug 5-fluorouracil, they upregulate CD34. Cells expanded in culture with growth factors likewise become CD34-positive, and only the CD34-positive fraction retains engraftment capability during that active phase. But when those cells are transplanted back into a recipient and allowed to return to a resting state, the long-term engrafting stem cells revert to CD34-negative.4Blood. Reversible Expression of CD34 by Murine Hematopoietic Stem Cells CD34 in the mouse blood system, then, is less of a permanent identity badge and more of a signal that the cell is currently active.
This reversibility has practical consequences. If you are sorting mouse bone marrow for transplantation experiments, the activation status of the donor matters. A mouse that received 5-FU a few days earlier will yield a stem cell pool with different CD34 characteristics than an untreated mouse. Experimental protocols that involve any kind of stress, infection, or cytokine stimulation before harvest can shift the CD34 profile in ways that alter which fraction contains the true long-term repopulating cells.
What Happens When You Delete CD34 Entirely
Knockout mice lacking CD34 altogether develop to adulthood and appear grossly normal, with typical blood counts in circulation. But beneath that surface normality, there are measurable defects. Progenitor cells from both bone marrow and spleen show reduced colony-forming activity, and when cultured with growth factors they fail to expand the way normal progenitors do.5Blood. Hematopoietic Defects in Mice Lacking the Sialomucin CD34 Embryonic blood development is also delayed in CD34-null animals, with fewer progenitors in the yolk sac and fetal liver. Interestingly, this delay can be rescued by re-introducing either the full-length or a truncated version of CD34, showing the effect is specific to the molecule.
Despite the progenitor defects, CD34-null mice recover from radiation-induced bone marrow damage at the same pace as normal mice. Their red blood cells, white blood cells, and platelets all bounce back on a normal schedule.6Blood. Hematopoietic defects in mice lacking the sialomucin CD34 This paradox, reduced progenitor numbers but normal recovery, hints at redundancy in the system. CD34 belongs to a small family of related sialomucins that includes podocalyxin and endoglycan, both of which are expressed on overlapping cell types. Researchers have speculated that one or both of these relatives partially compensate when CD34 is absent, and compound knockout studies targeting multiple family members are in progress to test this.7PLOS ONE. Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion
CD34 in Mouse Hair Follicles and Skin Tumors
CD34 in mice is not limited to the blood system. One of the most well-characterized non-hematopoietic sites of CD34 expression is the hair follicle bulge region, a niche containing slow-cycling, multipotent stem cells. In mice, CD34 marks these bulge cells and is functionally important for their behavior.8PubMed Central. CD34 expression by hair follicle stem cells is required for skin tumor development in mice Hair follicles in CD34-knockout mice tend to stay in their resting phase rather than cycling into active growth, and the labeled stem cells within the bulge remain quiescent instead of activating in response to stimulation.
The tumor connection is direct. In a standard two-stage chemical carcinogenesis protocol, where a cancer-initiating mutation is followed by repeated stimulation to promote tumor growth, CD34-knockout mice are strongly resistant to skin tumor formation. The hair follicle stem cells, which are a major source of chemically induced skin tumors in mice, simply do not activate and proliferate the way they need to in order for tumors to develop.9PubMed Central. CD34 expression by hair follicle stem cells is required for skin tumor development in mice This finding links CD34 not just to stem cell identity but to the functional activation of those cells in a disease-relevant context. It is worth noting that human hair follicle stem cells do not express CD34 in the same pattern, so the mouse finding does not translate directly to human skin cancer biology.
CD34 in Muscle Regeneration
Satellite cells, the resident stem cells of skeletal muscle, include a CD34-expressing subset in mice. These are not blood-derived cells that wandered into the muscle; they sit in the classic satellite cell position beneath the basement membrane of muscle fibers.10Experimental Hematology. A population of satellite cells expressing CD34 represent a type of muscle stem cell in mice The CD34-positive fraction within this population carries essentially all of the myogenic activity. In limiting dilution assays, roughly one in 31 CD34-positive cells could initiate a colony containing mature muscle fibers, compared to about one in 2,900 in the CD34-negative fraction.11PubMed Central. CD34 Promotes Satellite Cell Motility and Entry into Proliferation to Facilitate Efficient Skeletal Muscle Regeneration
Functionally, CD34 on satellite cells promotes their motility and their entry into proliferation, both of which are critical for efficient muscle repair after injury. Without CD34, satellite cells are slower to move toward damaged tissue and slower to begin dividing. For researchers studying muscle regeneration or muscular dystrophy models in mice, CD34 is a useful marker for enriching the stem cell fraction, but it also appears to be a genuine functional player rather than just a passive label.
Vascular Roles and Developmental Expression
CD34 is expressed on vascular endothelial cells in mice, a pattern that begins early in embryonic development. In the day-10 mouse embryo, CD34-positive cells are abundant in the liver, and a smaller number mark hematopoietic precursors in the yolk sac blood islands.12Blood. CD34 Expression Patterns During Early Mouse Development Are Related to Modes of Blood Vessel Formation and Reveal Additional Sites of Hematopoiesis The expression pattern during development correlates with specific modes of blood vessel formation, providing researchers a way to track how the vascular network assembles.
In adult mice, CD34’s vascular role extends to disease. In a model of oxygen-induced retinopathy, a condition that mimics aspects of diabetic eye disease and retinopathy of prematurity, CD34-knockout mice developed normal blood vessel networks within the retina during development. However, when challenged to form the abnormal, invasive new vessels that characterize pathological retinal disease, the knockout mice produced fewer of these harmful vascular tufts.13PLOS ONE. CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy CD34 seems dispensable for normal vascular development but contributes to the pathological overgrowth of vessels. This distinction makes it an interesting potential target in diseases driven by abnormal blood vessel formation.
CD34 and Inflammation
Beyond its roles in stem cells and vasculature, CD34 influences how inflammatory cells migrate into tissue during infection. In a mouse model of Salmonella gut infection, CD34-knockout mice showed delayed development of intestinal pathology and improved survival compared to normal mice. The mechanism appeared to be a defect in the migration of inflammatory cells into the intestinal tissue. Without CD34, fewer immune cells arrived at the site of infection, which reduced the tissue damage caused by the immune response itself.14PubMed. CD34 mediates intestinal inflammation in Salmonella-infected mice
This is a case where losing a molecule that sounds like it should be protective actually helps the animal survive, because the inflammation the immune system produces in response to Salmonella is itself a major cause of damage. The finding positions CD34 as a contributor to immunopathology in the gut and raises questions about whether blocking CD34-mediated migration might reduce collateral damage during severe intestinal infections.
CD34 in the Lymph Node Stroma and Heart
Single-cell RNA sequencing has expanded the map of where CD34 shows up in the mouse body. In lymph nodes, CD34 marks a distinct population of stromal cells located in the capsule and in the adventitia of medullary blood vessels. These are not blood-forming or endothelial cells but rather a structural population within the node’s scaffolding.15Immunity. Single-Cell RNA Sequencing Resolution of Lymph Node Stromal Cell Heterogeneity On endothelial cells within the lymph node, CD34 can bind L-selectin on circulating lymphocytes, facilitating their entry into the node, which connects CD34 back to its broader function in cell adhesion and migration.
In the heart, single-cell studies have tracked CD34-positive cells during the progression of cardiac hypertrophy in mice. An analysis of nearly 60,000 single cells from mouse hearts and over 22,000 from human hearts mapped changes in the cellular landscape as the heart progresses toward failure, identifying CD34-positive cells alongside fibroblasts, endothelial cells, and immune cells as part of the shifting population.16PubMed Central. Single cell and lineage tracing studies reveal the impact of CD34 + cells on myocardial fibrosis during heart failure Lineage tracing suggests these CD34-positive cells contribute to wound healing responses and may play a role in the fibrosis that stiffens the failing heart. Whether CD34 is a passive marker on these cells or an active participant in fibrotic remodeling is still under investigation.
Detecting CD34 in Mouse Tissue
One practical challenge that shaped the history of CD34 research in mice was antibody quality. Early attempts to study murine CD34 relied on polyclonal antibodies that gave poor resolution. The development of the RAM34 monoclonal antibody was a turning point, allowing researchers to detect CD34 on roughly four to seventeen percent of mouse bone marrow cells at intermediate to high expression levels.17Blood. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen Before RAM34, many experiments that reported mouse stem cells as “CD34-negative” may have been limited by the inability to detect low-level expression rather than its true absence. Researchers choosing antibody clones for flow cytometry or immunohistochemistry on mouse tissue should be aware that clone selection still affects sensitivity.
The differences between human and mouse CD34 also mean that antibodies are not cross-reactive. An antibody raised against human CD34 will not stain mouse CD34, and vice versa. Forced expression of human CD34 on mouse cells produces a protein that functions differently from native mouse CD34 in adhesion assays: it enhanced binding to human but not mouse bone marrow stromal layers, and this adhesion could be further increased by crosslinking the human CD34 molecule with antibodies.18PubMed Central. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion This species specificity underscores that mouse studies of CD34 need mouse-specific reagents, and findings about human CD34 function do not automatically carry over.
How RUNX1 Controls CD34 Gene Expression
Understanding why human and mouse CD34 behave differently at the transcriptional level has required detailed work on gene regulation. The transcription factor RUNX1, which is essential for establishing the blood cell gene expression program, controls human CD34 through a regulatory element located downstream of the gene itself. In transgenic mice carrying human CD34 constructs, this element was required for expression in long-term stem cells, and deleting RUNX1 shut the human transgene down entirely.19PubMed Central. RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element Physical interaction between this distant regulatory element and the promoter was confirmed in stem cells, and when the specific binding sites for RUNX1 were mutated, both the physical interaction and gene expression dropped.
The mouse CD34 gene likely has its own regulatory architecture that responds differently to RUNX1 or other factors, which would explain why the same cell type in the same animal can have human CD34 turned on while mouse CD34 stays off. Decoding these regulatory differences matters for anyone using CD34-reporter constructs, conditional knockouts driven by CD34 regulatory elements, or humanized CD34 models. The species difference is not just about the protein; it is wired into the gene’s control switches.
CD34 in Mouse Tumor Biology Beyond Skin
In mouse tumors, CD34 marks blood vessel endothelium, making anti-CD34 staining a standard tool for measuring tumor angiogenesis in preclinical studies. Researchers quantify microvessel density in tumor sections by counting CD34-positive structures. However, an important caveat emerged from studies of lymphatic vessels in tumors: while human tumor-associated lymphatic endothelial cells can express CD34, their mouse counterparts in experimental tumors do not.20PubMed Central. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors This means that using CD34 as a pan-vascular stain in mouse tumors will label blood vessels but miss lymphatic vessels, potentially underestimating the total vascular network. Researchers studying lymphangiogenesis in mouse tumor models need alternative markers like LYVE-1 or podoplanin for the lymphatic compartment.
The broader picture is that CD34 in mice sits at the intersection of stem cell biology, vascular biology, tissue repair, and immune cell trafficking. Its expression pattern differs from humans in ways that matter for experimental design, and its function goes well beyond being a passive surface marker. In tissue after tissue, CD34 influences how cells move, stick to one another, and transition between quiescent and active states. For anyone using mouse models to study these processes, knowing where CD34 behaves as expected and where it departs from the human pattern is not optional background reading; it is the kind of detail that determines whether your experiment gives you an interpretable answer.